Clinical Decision Support to Increase Use of Medications for Opioid Use Disorder

Not yet recruitingOBSERVATIONAL
Enrollment

200,000

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

May 31, 2027

Conditions
Medication AbuseHarm ReductionOpioid Use DisorderSupportive Care
Interventions
OTHER

Medications for Opioid Use Disorder Pathway Clinical Decision Support (CDS)

Clinical decision support (CDS) in the form of an electronic health record (EHR)-integrated, provider-facing notification suggesting (a) the patient may be at risk for opioid use disorder and could benefit from screening, (b) patients with opioid use disorder would benefit from treatment with buprenorphine and (c) utilization of a clinical care pathway to help treat patients with opioid use disorder with buprenorphine as suggested by the Center for Disease Control and Prevention (CDC) guidelines.

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Colorado, Denver

OTHER

NCT06526286 - Clinical Decision Support to Increase Use of Medications for Opioid Use Disorder | Biotech Hunter | Biotech Hunter